2-5% miss across the board in Q1 and guidance cut.

Q1 25 sales and ‘adjusted’ EBITDA were a 3% beat.

Towards a tie up with Abanca or Unicaja?

Beat in Q1 but Wegovy sales are below expectations. FY25 sales guidance downgraded.

Very strong Q1 but FY guidance lowered due to tariffs impact.

Rumours of a takeover by Shell.